4 ms·
The article refers to results in animals which means it is probably years - maybe a decade - from being approved. Novo’s patent protection expires in 2033 [0] s
by docdeek 2y ago
The article refers to results in animals which means it is probably years - maybe a decade - from being approved. Novo’s patent protection expires in 2033 [0] so it could be that the market is not yet worried about a potential competitor that likely won’t get to market before the IP protection runs out.
[0]: https://www.reddie.co.uk/2024/08/30/the-year-of-ozempic-an-ip-take/ https://www.reddie.co.uk/2024/08/30/the-year-of-ozempic-an-i...
- llamaimperative 2y agoAnd Novo (like many others) is already working on next-generation GLPs that’ll have new patent protection before Ozempic’s ends.
- leereeves 2y agoEven so, competition from other GLP-1 drugs and generic semaglutide should make prices and profits lower.
- droopyEyelids 2y agoIf the companies combined can meet demand
- genewitch 2y agoThey seem to be able to offer it at $300 if you pay without insurance. The implication being that they make 50 extra bucks because the insurance company only pays $250 for your $1,000 prescription.